Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats

Piroxicam is an anti-inflammatory, analgesic and antipyretic drug. It is presently used for postoperative pain management in ruminants. However, female animals have been reported to be more sensitive to piroxicam. Hence its pharmacokinetic parameters were investigated in West African Dwarf (WAD) goa...

Full description

Bibliographic Details
Main Authors: Emmanuel Itodo Akogwu, Saganuwan Alhaji Saganuwan, Patrick Azubuike Onyeyili
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Cogent Food & Agriculture
Subjects:
Online Access:http://dx.doi.org/10.1080/23311932.2017.1294444
_version_ 1818431696962322432
author Emmanuel Itodo Akogwu
Saganuwan Alhaji Saganuwan
Patrick Azubuike Onyeyili
author_facet Emmanuel Itodo Akogwu
Saganuwan Alhaji Saganuwan
Patrick Azubuike Onyeyili
author_sort Emmanuel Itodo Akogwu
collection DOAJ
description Piroxicam is an anti-inflammatory, analgesic and antipyretic drug. It is presently used for postoperative pain management in ruminants. However, female animals have been reported to be more sensitive to piroxicam. Hence its pharmacokinetic parameters were investigated in West African Dwarf (WAD) goats. Ten goats divided into two groups, each comprised five females and five males were administered piroxicam at predetermined dose of 5 mg/kg body weight via thigh muscle. The blood samples were collected into EDTA bottles before the treatment and thereafter at 0.08, 0.16, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 24, 48, 72, 96, 120, 144, 168, and 192 h for analysis of piroxicam using a spectrophotometric method at 330 nm wavelength. Concentration maximum (Cmax = 543.2 ± 64.4 μg/ml), absorption rate constant (α = 1.2 ± 0.4 h), and elimination rate constant (β = 0.4 ± 0.2 h of the male WAD goats were significantly higher (p < 0.05) in comparison with Cmax (376.9 ± 61.2 μg/ml), α (0.8 ± 0.3 h) and β (0.3 ± 0.1 h) of the female WAD goats, respectively. The absorption half life (t1/2α = 1.6 ± 0.6 h), elimination half life (t1/2β = 5.2 ± 2.3 h), body clearance (Clb = 1.1 ± 0.2 L/kg/h), mean residence time (MRT = 7.8 ± 3.5 h) and mean absorption time (MAT = 1.8 ± 0.4 h) of the female WAD goats were significantly higher (p < 0.05) in comparison with t1/2α (0.9 ± 0.3 h), t1/2β (2.5 ± 0.6 h), Clb (0.4 ± 0.1L/kg/h), MRT (0.9 ± 0.6 h) and MAT (1.3 ± 0.5 h) of the male goats respectively. The percentage protein binding capacity in the species was 81.9%. But three out of five female goats were paralyzed. Hence female WAD goats may be more sensitive to piroxicam than male WAD goats.
first_indexed 2024-12-14T15:53:25Z
format Article
id doaj.art-f37cc34a74a946e5be2e07f44b884c1e
institution Directory Open Access Journal
issn 2331-1932
language English
last_indexed 2024-12-14T15:53:25Z
publishDate 2017-01-01
publisher Taylor & Francis Group
record_format Article
series Cogent Food & Agriculture
spelling doaj.art-f37cc34a74a946e5be2e07f44b884c1e2022-12-21T22:55:19ZengTaylor & Francis GroupCogent Food & Agriculture2331-19322017-01-013110.1080/23311932.2017.12944441294444Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goatsEmmanuel Itodo Akogwu0Saganuwan Alhaji Saganuwan1Patrick Azubuike Onyeyili2University of AgricultureUniversity of AgricultureUniversity of AgriculturePiroxicam is an anti-inflammatory, analgesic and antipyretic drug. It is presently used for postoperative pain management in ruminants. However, female animals have been reported to be more sensitive to piroxicam. Hence its pharmacokinetic parameters were investigated in West African Dwarf (WAD) goats. Ten goats divided into two groups, each comprised five females and five males were administered piroxicam at predetermined dose of 5 mg/kg body weight via thigh muscle. The blood samples were collected into EDTA bottles before the treatment and thereafter at 0.08, 0.16, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, 8, 10, 12, 24, 48, 72, 96, 120, 144, 168, and 192 h for analysis of piroxicam using a spectrophotometric method at 330 nm wavelength. Concentration maximum (Cmax = 543.2 ± 64.4 μg/ml), absorption rate constant (α = 1.2 ± 0.4 h), and elimination rate constant (β = 0.4 ± 0.2 h of the male WAD goats were significantly higher (p < 0.05) in comparison with Cmax (376.9 ± 61.2 μg/ml), α (0.8 ± 0.3 h) and β (0.3 ± 0.1 h) of the female WAD goats, respectively. The absorption half life (t1/2α = 1.6 ± 0.6 h), elimination half life (t1/2β = 5.2 ± 2.3 h), body clearance (Clb = 1.1 ± 0.2 L/kg/h), mean residence time (MRT = 7.8 ± 3.5 h) and mean absorption time (MAT = 1.8 ± 0.4 h) of the female WAD goats were significantly higher (p < 0.05) in comparison with t1/2α (0.9 ± 0.3 h), t1/2β (2.5 ± 0.6 h), Clb (0.4 ± 0.1L/kg/h), MRT (0.9 ± 0.6 h) and MAT (1.3 ± 0.5 h) of the male goats respectively. The percentage protein binding capacity in the species was 81.9%. But three out of five female goats were paralyzed. Hence female WAD goats may be more sensitive to piroxicam than male WAD goats.http://dx.doi.org/10.1080/23311932.2017.1294444piroxicampharmacokineticswest african dwarf goatsintramuscularparalysis
spellingShingle Emmanuel Itodo Akogwu
Saganuwan Alhaji Saganuwan
Patrick Azubuike Onyeyili
Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
Cogent Food & Agriculture
piroxicam
pharmacokinetics
west african dwarf goats
intramuscular
paralysis
title Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
title_full Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
title_fullStr Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
title_full_unstemmed Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
title_short Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats
title_sort comparative pharmacokinetics of piroxicam in male and female west african dwarf goats
topic piroxicam
pharmacokinetics
west african dwarf goats
intramuscular
paralysis
url http://dx.doi.org/10.1080/23311932.2017.1294444
work_keys_str_mv AT emmanuelitodoakogwu comparativepharmacokineticsofpiroxicaminmaleandfemalewestafricandwarfgoats
AT saganuwanalhajisaganuwan comparativepharmacokineticsofpiroxicaminmaleandfemalewestafricandwarfgoats
AT patrickazubuikeonyeyili comparativepharmacokineticsofpiroxicaminmaleandfemalewestafricandwarfgoats